Abstract

Among patients at high risk for cardiovascular events but without diabetes, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, resulted in lower rates of fatal and nonfatal major cardiovascular events and death from any cause, although significantly higher rates of some adverse events were observed in the intensive-treatment group. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT01206062.).

Keywords

Blood pressureMedicineRandomized controlled trialDiabetes mellitusCardiologyIntensive care medicineInternal medicineEmergency medicineEndocrinology

Affiliated Institutions

Related Publications

Publication Info

Year
2015
Type
article
Volume
373
Issue
22
Pages
2103-2116
Citations
5933
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

5933
OpenAlex

Cite This

The SPRINT Research Group, The SPRINT Research Group (2015). A Randomized Trial of Intensive versus Standard Blood-Pressure Control. New England Journal of Medicine , 373 (22) , 2103-2116. https://doi.org/10.1056/nejmoa1511939

Identifiers

DOI
10.1056/nejmoa1511939